Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
45.00%
↑ 1712% above average
Average (14q)
-2.79%
Historical baseline
Range
High:45.00%
Low:-50.94%
Volatility
-3437.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 45.00% |
| Q2 2025 | 39.39% |
| Q1 2025 | -26.92% |
| Q4 2024 | 12.36% |
| Q3 2024 | -39.06% |
| Q2 2024 | 16.88% |
| Q1 2024 | -48.08% |
| Q4 2023 | 35.00% |
| Q3 2023 | -50.94% |
| Q2 2023 | 28.38% |
| Q1 2023 | -27.59% |
| Q4 2022 | 14.71% |
| Q3 2022 | -13.33% |
| Q2 2022 | -27.66% |
| Q1 2022 | 0.00% |